WP Engine, a WordPress software producer that counts WordPress operator Automattic as an investor, has raised $250m from Silver Lake.
Author: Robert Lavine
GV collaborates with Quartet in $40m round
Quartet, the creator of a collaborative healthcare platform, took its total funding to $87m with a series C round featuring existing backer GV.
Mogoroom’s funding quest leads to Giant
Giant Network Group and its Giant Investment unit have put up $19m of the $29.3m raised by housing rental platform Mogoroom.
Scholar Rock plays on in $47m series C
Scholar Rock will use the proceeds from the Kraft Group-backed round to advance its lead spinal muscular atrophy drug candidate into clinical development.
Didi Chuxing digs out $600m for 99
The on-demand ride provider reportedly now owns a 90% share of its Brazilian counterpart, whose investors also included Qualcomm and SoftBank.
Spotify confidentially files for direct listing
The music streaming platform, which is backed by several corporates, has reportedly filed to go public in the US and could demand a $19bn valuation.
Restorbio readies $85m initial public offering
Restorbio, an aging-related disease drug developer co-founded by PureTech Health, also counts Novartis as a shareholder.
Boehringer Ingelheim boosts CVC fund to $300m
The pharmaceutical firm more than doubled the size of its Boehringer Ingelheim Venture Fund, which has scored exits in two nine-figure acquisitions.
Armo arcs to IPO stage
GV and Celgene-backed Armo BioSciences has filed to raise up to $86.3m in an offering that will fund clinical tests for its lead immuno-oncology candidate.
DNAnexus stores $58m in new financing
Microsoft joined a consortium including existing investors GV and WuXi NextCode to take the biomedical data platform’s overall financing to $105m.
Menlo Therapeutics eases way to IPO
The Novo and Merck-backed pruritus therapy developer has filed to raise up to $97.8m, having already secured almost $110m in VC funding.
Alibaba considers $100m Xpressbees delivery
Alibaba is reportedly in the final stages of talks for an investment of up to $100m in e-commerce logistics provider Xpressbees.
Solid Bio to sound out public markets
Biogen-backed Duchenne muscular dystrophy (DMD) treatment developer Solid Biosciences has filed to raise up to $100m.
Katerra begins building next funding round
The Foxconn-backed construction services provider, valued at more than $1bn as of April 2017, has raised $28.8m and could close the round at up to $200m.